UnitedHealth Group Incorporated UNH
- Market cap
- $336.8B
- P/E
- 24.2×
Follow UNH
UnitedHealth Group Incorporated (UNH) EV/EBITDA
As of 25 September 2026, UnitedHealth Group Incorporated (UNH) trades at a EV/EBITDA of 14.5×. Over the past ten years it has ranged from 7.4× (August 2025) to 19.8× (December 2021); the current reading is higher than 74% of that period. That is above the Healthcare Plans industry median of 10.9× and above the Healthcare sector median of 10.4×.
EV/EBITDA, daily
Annual
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 14.7× | 5.38% |
| FY2024 | 14.0× | (3.93%) |
| FY2023 | 14.6× | (9.54%) |
| FY2022 | 16.1× | (11.40%) |
| FY2021 | 18.2× | 30.72% |
| FY2020 | 13.9× | 3.09% |
| FY2019 | 13.5× | 2.49% |
| FY2018 | 13.2× | 1.38% |
| FY2017 | 13.0× | 17.02% |
| FY2016 | 11.1× | 13.24% |
Quarterly
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 15.9× | 28.87% |
| Mar 2026 | 12.3× | (16.30%) |
| Dec 2025 | 14.7× | 27.41% |
| Sep 2025 | 11.6× | 24.77% |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| CNC Centene Corporation compare | n/m |
| CI Cigna Group compare | 7.7× |
| OSCR Oscar Health, Inc. compare | 8.4× |
| CVS CVS Health Corporation compare | 8.7× |
| ELV Elevance Health, Inc. compare | 9.0× |
| HUM Humana Inc. compare | 10.9× |
| MOH Molina Healthcare, Inc compare | 13.0× |
| UNH UnitedHealth Group Incorporated | 14.5× |
| Healthcare Plans industry median | 10.9× |
| Healthcare sector median | 10.4× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on UNH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement